Patients Before Patents or Profits
A dose of success for patient rights in India as the Indian Patent Office rejected J&J’s application to extend its monopoly over selling miracle anti-Tuberculosis drug Bedaquiline after a plea filed by two TB survivors. But is this a one off or will this push MNCs to rethink their drug monopoly strategy? Does the…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Morning Brief
See all episodes →
Similar episodes from other shows
More like The Morning Brief →
India’s TB patients can finally celebrate the end of Johnson & Johnson’s monopoly disguised as charity
Exposing a Pharma secret: Evergreening!
Can India break this Pharma Monopoly?
Overhauling drugs law, Maha's new bike taxi rules, and Tata Sons' chairman
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.